EMP-15972-15512
3 vaccinations
13 coded responses
38 check-ins
12 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 305 / GA
- Registered
- 2021-09-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-10
Registered in v-safe
-
2021-09-10
Dose 1 — Pfizer-BioNTech
-
2021-09-10
Survey response — day 0, dose 1MedDRA: Arthralgia, Back pain, Hypoaesthesia, Musculoskeletal pain, Tenderness — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal painFree text: Numbness in left buttock, backache, shoulder and shoulder blade pain, tenderness in left thighMedDRA releases: 2024-11 · check-in free text available
-
2021-09-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-12
Survey response — days 1–6 daily, dose 1MedDRA: Injection site erythema, Injection site warmth — Feeling: Good · Site: Pain, Redness, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal painFree text: Redness around injection site feels hotMedDRA releases: 2024-11 · check-in free text available
-
2021-09-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-09-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Joint pains, Nausea, DiarrheaAdult check-in
- 2021-09-15
- 2021-09-16
- 2021-09-17
- 2021-09-24
-
2021-10-01
Dose 2 — Pfizer-BioNTech
-
2021-10-01
Survey response — day 0, dose 2MedDRA: Arthralgia, Back pain — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Abdominal painFree text: Shoulder pain and joint pain in lower backMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-10-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-10-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-05
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite, Menstruation irregular — Feeling: Good · Fatigue or tirednessFree text: Loss of appetite and missed menstrual period since first doseMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-07
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Poor · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Loss of appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Survey response — day 7, dose 2MedDRA: Brain fog, Decreased appetite — Feeling: Good · Fatigue or tirednessFree text: Loss of appetite, brain fogMedDRA releases: 2024-11 · check-in free text available
-
2021-10-15
Survey response — day 14, dose 2MedDRA: Decreased appetite, Dysmenorrhoea, Fatigue, Heavy menstrual bleeding — Feeling: Good · Be unable to do your normal daily activitiesFree text: Decreased appetite, lingering fatigue, heavier and more painful menstrual periodsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-22
Survey response — day 21, dose 2MedDRA: Brain fog, Decreased appetite, Dysmenorrhoea, Fatigue, Heavy menstrual bleeding — Feeling: GoodFree text: Heavier and more painful menstruation, brain fog, fatigue, loss of appetiteMedDRA releases: 2024-11 · check-in free text available
- 2021-10-29
-
2021-11-07
Survey response — day 35, dose 2MedDRA: Brain fog, Decreased appetite, Dysmenorrhoea, Fatigue, Heavy menstrual bleeding — Feeling: GoodFree text: Heavier and painful menstruation, loss of appetite, brain fog, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2021-11-12
Survey response — day 42, dose 2MedDRA: Brain fog, Decreased appetite, Dysmenorrhoea, Fatigue, Heavy menstrual bleeding — Feeling: GoodFree text: Heavier and painful menstrual periods, fatigue, brain fog, and loss of appetiteMedDRA releases: 2024-11 · check-in free text available
- 2021-12-31
-
2022-02-28
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-03-01
Survey response — days 1–6 daily, dose 3MedDRA: Asthenia, Brain fog, Dizziness — Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessFree text: Weakness, lightheadedness, brain fogMedDRA releases: 2024-11 · check-in free text available
-
2022-03-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness, Abdominal painAdult check-in
-
2022-03-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2022-03-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2022-03-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Itching · Headache, Fatigue or tirednessAdult check-in
-
2022-03-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
- 2022-03-07
- 2022-03-14
- 2022-03-21
- 2022-03-28
-
2022-04-04
Survey response — day 35, dose 3MedDRA: Dysmenorrhoea, Heavy menstrual bleeding — Feeling: FairFree text: More painful and heavier menstrual cycleMedDRA releases: 2024-11 · check-in free text available
- 2022-04-11
- 2022-05-30
- 2022-08-29
-
2023-02-28
Survey response — 12 months, dose 3MedDRA: Cough, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-10 | Pfizer-BioNTech | No |
| 2 | 2021-10-01 | Pfizer-BioNTech | No |
| 3 | 2022-02-28 | Pfizer-BioNTech | Flu |
Free text
Release 9 — day 0, dose 1
Systemic reaction (other): Numbness in left buttock, backache, shoulder and shoulder blade pain, tenderness in left thigh
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Redness around injection site feels hot
Release 9 — day 0, dose 2
Systemic reaction (other): Shoulder pain and joint pain in lower back
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Loss of appetite and missed menstrual period since first dose
Systemic reaction (other): Loss of appetite
Release 10 — day 7, dose 2
Systemic reaction (other): Loss of appetite, brain fog
Release 10 — day 14, dose 2
Symptoms: Decreased appetite, lingering fatigue, heavier and more painful menstrual periods
Release 10 — day 21, dose 2
Symptoms: Heavier and more painful menstruation, brain fog, fatigue, loss of appetite
Release 10 — day 35, dose 2
Symptoms: Heavier and painful menstruation, loss of appetite, brain fog, fatigue
Release 10 — day 42, dose 2
Symptoms: Heavier and painful menstrual periods, fatigue, brain fog, and loss of appetite
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Weakness, lightheadedness, brain fog
Release 11 — day 35, dose 3
Symptoms: More painful and heavier menstrual cycle
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Dysmenorrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Arthralgia | · | · | ✓ |
| SRO | Asthenia | · | · | ✓ |
| SRO | Back pain | · | · | ✓ |
| SRO | Brain fog | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Hypoaesthesia | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site warmth | · | · | ✓ |
| SRO | Menstruation irregular | · | · | ✓ |
| SRO | Musculoskeletal pain | · | · | ✓ |
| SRO | Tenderness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release